You can:
Name | Glucose-dependent insulinotropic receptor |
---|---|
Species | Homo sapiens (Human) |
Gene | GPR119 |
Synonym | GPCR2 GPR119 G-protein coupled receptor 2 G-protein coupled receptor 119 G protein-coupled receptor 119 [ Show all ] |
Disease | Type 2 diabetes Diabetes Peripheral arterial disease; Type 2 diabetes Non-insulin dependent diabetes Gastric cancer; Type 2 diabetes |
Length | 335 |
Amino acid sequence | MESSFSFGVILAVLASLIIATNTLVAVAVLLLIHKNDGVSLCFTLNLAVADTLIGVAISGLLTDQLSSPSRPTQKTLCSLRMAFVTSSAAASVLTVMLITFDRYLAIKQPFRYLKIMSGFVAGACIAGLWLVSYLIGFLPLGIPMFQQTAYKGQCSFFAVFHPHFVLTLSCVGFFPAMLLFVFFYCDMLKIASMHSQQIRKMEHAGAMAGGYRSPRTPSDFKALRTVSVLIGSFALSWTPFLITGIVQVACQECHLYLVLERYLWLLGVGNSLLNPLIYAYWQKEVRLQLYHMALGVKKVLTSFLLFLSARNCGPERPRESSCHIVTISSSEFDG |
UniProt | Q8TDV5 |
Protein Data Bank | N/A |
GPCR-HGmod model | Q8TDV5 |
3D structure model | This predicted structure model is from GPCR-EXP Q8TDV5. |
BioLiP | N/A |
Therapeutic Target Database | T93788 |
ChEMBL | CHEMBL5652 |
IUPHAR | 126 |
DrugBank | N/A |
Name | CHEMBL3357999 |
---|---|
Molecular formula | C20H17F4N7O2 |
IUPAC name | 3-fluoro-4-[[2-[(2R)-2-methyl-4-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]piperazin-1-yl]pyrimidin-5-yl]oxymethyl]benzonitrile |
Molecular weight | 463.397 |
Hydrogen bond acceptor | 13 |
Hydrogen bond donor | 0 |
XlogP | 3.1 |
Synonyms | BDBM50103558 |
Inchi Key | DJPAKBMZZYZGIM-GFCCVEGCSA-N |
Inchi ID | InChI=1S/C20H17F4N7O2/c1-12-10-30(19-29-28-17(33-19)20(22,23)24)4-5-31(12)18-26-8-15(9-27-18)32-11-14-3-2-13(7-25)6-16(14)21/h2-3,6,8-9,12H,4-5,10-11H2,1H3/t12-/m1/s1 |
PubChem CID | 118722575 |
ChEMBL | CHEMBL3357999 |
IUPHAR | N/A |
BindingDB | 50103558 |
DrugBank | N/A |
Structure | |
Lipinski's druglikeness | This ligand has more than 10 hydrogen bond acceptor. |
Parameter | Value | Reference | Database source |
---|---|---|---|
EC50 | 15.0 nM | PMID25286150 | BindingDB,ChEMBL |
Intrinsic activity | 156.0 % | PMID25286150 | ChEMBL |
zhanglabzhanggroup.org | +65-6601-1241 | Computing 1, 13 Computing Drive, Singapore 117417